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OBJECTIVES We sought to compare U.S. and Canada’s post-myocardial infarction (MI) cardiac catheter-
ization practices in the detection of severe coronary artery disease (CAD).
BACKGROUND Little is known about the efficiency with which the aggressive post-MI catheterization
strategy observed in the U.S. detects severe CAD compared with the more conservative
strategy observed in Canada.
METHODS From the U.S. and Canadian patients who had participated in the Global Utilization of
Streptokinase and Tissue Plasminogen Activator for Occluded Arteries trial (n 5 22,280,
11.5% Canadian), we examined the frequency of in-hospital cardiac catheterization, the
prevalence of severe CAD observed at catheterization (diagnostic efficiency) and the total
number of MI patients with severe CAD identified (diagnostic yield).
RESULTS The rate of catheterization in the U.S. was more than 2.5 times that in Canada (71% vs. 27%,
respectively, p , 0.001). With identical prevalences of severe CAD at catheterization (17%)
in the two countries, the higher frequency of catheterization in the U.S. resulted in the
identification of more than two and a half times as many cases of severe CAD compared with
Canada (12 severe CAD cases identified per 100 post-MI patients in the U.S., vs. 4.6 per 100
in Canada). If considered in isolation, we estimated that these differences in severe disease
detection might effect a small long-term survival advantage in favor of the U.S. strategy
(estimated 5.0 lives saved per 1,000 MI patients).
CONCLUSIONS Canada’s more restrictive post-MI cardiac catheterization strategy is no more efficient in
identifying severe CAD than the aggressive U.S. strategy, and may fail to identify a
substantial number of post-MI patients with high risk coronary anatomy. The long-term
impact of these differences in practice patterns requires further evaluation. (J Am Coll
Cardiol 1999;34:12–9) © 1999 by the American College of Cardiology
Examination of the healthcare systems in the U.S. and
Canada has become a standard for comparing patient
See pages 20 and 23
outcomes between a technologically driven multipayer sys-
tem (i.e., U.S.) and a more conservative, government-
regulated healthcare system (i.e., Canada). Within the arena
of cardiovascular healthcare, such comparisons have focused
on differences in the management patterns after myocardial
infarction (MI) (1–3). These studies have revealed that
patients with MI in the U.S. are more likely to undergo
diagnostic cardiac catheterization and revascularization pro-
cedures than are their Canadian counterparts. Despite
reports suggesting gains in quality of life and functional
status (1,3), more aggressive catheterization practices have
not yet been shown to benefit short-term post-MI survival
(1–8).
One of the primary purposes of catheterization after MI
is to identify patients with severe coronary artery disease
(CAD), such as triple-vessel disease (3VD) or left main
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coronary artery disease (LMD), who could achieve a survival
benefit from surgical revascularization (9–12). With regard
to the detection of severe CAD, different post-MI cathe-
terization practice patterns can be evaluated by comparing
their respective diagnostic efficiency (number of post-MI
patients with severe CAD identified divided by the number
of catheterizations performed), and diagnostic yield (total
number of patients with severe CAD identified from the
post-MI population). For example, by preferentially per-
forming catheterization on patients with a high pre-test
likelihood of severe CAD, a constrained healthcare system
could maximize diagnostic efficiency by eliminating unnec-
essary catheterizations on those patients unlikely to have
severe CAD. However, the same strategy, should it become
too restrictive, might fail to identify some patients in the
post-MI population with severe CAD, thereby reducing the
overall diagnostic yield of the catheterization strategy.
The primary objective of this study was to compare U.S.
and Canadian catheterization practices with respect to their
diagnostic efficiency and yield in detecting severe CAD after
MI. Second, to gain insight into the catheterization patterns
within each of these healthcare systems, we examined the
clinical characteristics predictive of cardiac catheterization
and of severe CAD in the two countries. Our final objective
was to estimate how any observed differences between U.S.
and Canadian yields of severe CAD post-MI might affect
long-term outcome.
METHODS
Study population. We studied patients from the U.S. and
Canada who were enrolled in the GUSTO-1 trial (13). The
eligibility criteria and results of this trial, which compared
four thrombolytic strategies for acute MI, have been re-
ported previously (13). We considered the 26,003 patients
randomized into the study from U.S. (n 5 23,105) and
Canadian (n 5 2,898) sites. From this cohort, a total of
3,723 patients who either had a prior revascularization
procedure (n 5 2,517), or had participated in the GUSTO
Angiographic Substudy (14) (a subgroup of randomly se-
lected GUSTO patients all of whom underwent cardiac
catheterization by protocol, n 5 1,154), were excluded.
However, patients from the angiographic substudy were
studied separately to develop a model predictive of severe
CAD based on baseline clinical characteristics (see below).
The remaining 22,280 patients (19,739 U.S. and 2,541
Canadian patients), in whom cardiac catheterization was
left to the discretion of the attending physician, formed our
final study cohort.
Cardiac catheterization results and practice patterns.
Baseline clinical characteristics and in-hospital cardiac cath-
eterization results were derived from the GUSTO Trial
Case Report Form (13). Severe CAD was defined as either
the presence of a $70% stenosis in all three major epicardial
coronary arteries, or a $50% stenosis in the left main
coronary artery on visual angiographic assessment, as inter-
preted by the site physician performing the cardiac cathe-
terization. By examining the rates and angiographic results
of in-hospital post-MI cardiac catheterization, we calcu-
lated the diagnostic efficiency and diagnostic yield for the
detection of severe CAD in the U.S. and Canada. To gain
insights into clinical factors influencing the selection for
cardiac catheterization, we examined each country’s rate of
catheterization after stratification by age (both by decade,
and after dichotomizing age into ,75 vs. $75 years),
gender, diabetes mellitus, MI location (anterior vs. other),
prior MI, Killip class (I vs. $II), recurrent myocardial
ischemia and occurrence of any post-MI complication (i.e.,
shock, pulmonary edema, congestive heart failure, recurrent
ischemia, sustained ventricular tachycardia, ventricular fi-
brillation or recurrent myocardial infarction). These rates of
catheterization were then compared to the group’s corre-
sponding likelihood of severe CAD to relate cardiac cath-
eterization practice patterns to the risk of severe CAD.
Estimating the prevalence of severe CAD. Comparisons
between U.S. and Canadian cardiac catheterization prac-
tices should ideally correct for the underlying prevalence of
severe CAD in the two countries. We estimated each
country’s prevalence of severe CAD in two ways. First, we
directly observed the prevalence of severe CAD in the U.S.
and Canadian patients (n 5 1,154, 14% Canadian) from the
GUSTO Angiographic Substudy (14). Second, using the
clinical and angiographic data from this substudy, we
developed a logistic regression model predicting the likeli-
hood of severe CAD based on baseline clinical characteris-
tics. Clinical variables demonstrating a significant univariate
association with the presence of severe CAD (p , 0.05)
were entered, in a forward stepwise fashion, into a multi-
variable model with the presence of severe CAD modeled as
the dependent variable. This model was then applied to our
cohorts in the U.S. and Canada to determine whether the
overall predicted probability of severe CAD differed be-
tween patients from these two countries.
Potential impact on long-term outcome. If one health-
care system identifies and revascularizes more post-MI
patients with severe CAD than another, then we might
anticipate the former system to effect a long-term survival
benefit relative to the other healthcare system (12). To
estimate this potential survival difference, we assumed that
Abbreviations and Acronyms
CAD 5 coronary artery disease
CI 5 confidence interval
GUSTO-1 5 Global Utilization of Streptokinase and
Tissue Plasminogen Activator for
Occluded Arteries
LMD 5 left main coronary disease
MI 5 myocardial infarction
3VD 5 three-vessel coronary disease
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patients identified as having severe CAD in the two
countries would be equally likely to undergo surgical revas-
cularization (at a rate consistent with that observed in the
GUSTO trial). We then applied the marginal benefit of
surgical revascularization over medical therapy reported by
Yusuf et al. (12) to estimate the five-year survival gradient
that might accrue from any measured difference in severe
CAD yield between the two countries’ catheterization
practices. It must be recognized that the sole purpose of
these calculations was to achieve a gross estimate of the
potential long-term effects of the differences in these two
different catheterization strategies when considered in iso-
lation of other management practices.
RESULTS
Baseline clinical characteristics. Overall, the demo-
graphic and clinical characteristics of the U.S. and Canadian
patients were similar (Table 1). The U.S. cohort had a
slightly higher proportion of women, hypertension, diabe-
tes, hypercholesterolemia and patients with a family history
of coronary artery disease, and a slightly higher heart rate on
presentation. Canadian patients had a higher baseline mean
systolic blood pressure and were slightly more likely to have
had prior angina or MI.
Cardiac catheterization findings. In-hospital post-MI
cardiac catheterization was performed more than two and a
half times more frequently in the U.S. than in Canada (71%
vs. 27%, respectively, p , 0.001). Despite this, the findings
at catheterization were nearly identical; the proportion of
patients with no significant coronary stenoses and those
with one-, two- and three-vessel disease, and left main
disease were similar in the two countries (Table 2, p 5 NS
for all comparisons). Accordingly, the diagnostic efficiency
with which severe CAD was detected was also equal for the
two countries (17% of catheterized patients having severe
CAD in both the U.S. and Canada). However, due to the
Table 1. Baseline Clinical Characteristics
Variable
U.S.
(n 5 19,739)
Canada
(n 5 2,541) p Value*
Median age (yr) 61 (51, 70) 61 (52, 70) NS
Female 28 24 , 0.0001
Hypertension 42 33 , 0.0001
Diabetes mellitus 16 14 0.002
Current smoking 44 43 NS
Family history of CAD 48 46 0.018
Hypercholesterolemia 36 29 , 0.0001
Prior angina 31 36 0.001
Prior MI 12 14 0.002
Mean systolic BP (mm Hg) 127 (110, 142) 130 (114, 145) 0.001
Mean heart rate (beats/min) 76 (63, 86) 74 (62, 84) 0.001
Killip class I 88 87 NS
Anterior MI 38 41 NS
*NS denotes a p value $ 0.05. Values are expressed as percentages, except for continuous variables, which are given as medians
or means (followed in parentheses by the 25th and 75th percentiles).
BP 5 blood pressure; CAD 5 coronary artery disease; MI 5 myocardial infarction.
Table 2. Results of Cardiac Catheterization
U.S.
(n 5 19,739)
Canada
(n 5 2,541)
p
Value
Cardiac catheterizations 14,015 (71%) 686 (27%) , 0.001
None/insignificant CAD (%) 11 13 NS
One-vessel disease (%) 51 49 NS
Two-vessel disease (%) 26 26 NS
Three-vessel disease (%) 11 11 NS
Left main disease (%) 6 6 NS
Severe CAD
Diagnostic efficiency* 17 17 NS
(95% CI) (16.4–17.6) (14.2–19.8)
Diagnostic yield† 12 4.6 , 0.001
(95% CI) (11.5–12.5) (3.8–5.4)
*Number of patients with severe coronary artery disease (CAD) identified per 100 cardiac catheterizations. †Number of patients
with severe CAD identified per 100 patients with myocardial infarction.
CI 5 confidence interval.
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higher rate of catheterization in the U.S., the diagnostic
yield for severe CAD in the U.S. was more than two and a
half times that in Canada (12 cases of severe CAD identi-
fied per 100 MI patients in the U.S. compared with 4.6 per
100 in Canada, p , 0.001). Alternatively stated, for every
100 MI patients treated, the U.S. post-MI management
strategy identified an average of 7.4 more cases of severe
CAD than did Canadian practices (Fig. 1), at the expense of
performing 44 more catheterizations.
To ensure that these intercountry differences in the
identification of severe CAD did not result from a difference
in underlying disease prevalence, we estimated each coun-
try’s prevalence of severe CAD using two methods. First, we
examined the prevalence of severe CAD in the two coun-
tries as measured directly from the GUSTO Angiographic
Substudy (14) (Table 3). In this angiographic substudy, the
frequency of severe CAD was similar for U.S. and Canadian
patients (19% vs. 22%, respectively, p 5 NS). Second, we
estimated each country’s underlying likelihood for severe
disease based on their respective baseline risk factors.
Multivariable logistic regression identified age, previous MI,
male gender, previous coronary bypass surgery, previous
percutaneous coronary angioplasty, hyperlipidemia and
smoking history as independent clinical predictors of severe
CAD (see Appendix). The C-index for the predictive model
was 0.72. Applying this model to our entire sample pro-
duced a predicted prevalence of severe CAD of 18.7% for
U.S. patients, and 18.8% for Canadian patients (p 5 NS).
Thus, with both direct observation and indirect estimates,
we demonstrated that the underlying prevalence of severe
CAD was similar among the patients enrolled in the two
countries.
Relationship between cardiac catheterization rates and
the likelihood of severe CAD in clinical subgroups.
Comparisons of U.S. and Canadian cardiac catheterization
rates for each of the defined clinical subgroups are shown in
Table 4. United States physicians were two to three times
more likely than Canadian physicians to use cardiac cathe-
terization across a wide spectrum of patients. For each
clinical subgroup, we compared the likelihood of underlying
severe CAD juxtaposed against the likelihood of undergo-
ing catheterization in the U.S. and Canada (Fig. 2). Of
interest, several predictors of severe CAD (i.e., increased
age, diabetes, prior MI and higher Killip class) were
paradoxically associated with a lower likelihood of cardiac
catheterization in both countries. To further illustrate this
paradox, we specifically displayed the relationship between
the predicted probability of severe CAD and rates of cardiac
catheterization across various age decades (Fig. 3). Al-
though catheterization was performed with significantly
Figure 1. Pie graphs comparing findings at cardiac catheterization
in the U.S. and Canada with respect to catheterization frequency
and the presence or absence of severe coronary artery disease
(CAD). Open 5 no catheterization; gray 5 nonsevere CAD;
solid 5 severe CAD.
Table 3. Prevalence of Coronary Artery Disease in the GUSTO
Angiographic Substudy
U.S.
(n 5 994)
Canada
(n 5 160) p Value
One-vessel disease (%) 54 50 NS
Two-vessel disease (%) 27 28 NS
Three-vessel disease (%) 14 15 NS
Left main disease (%) 5 7 NS
Severe CAD* (%) 19 22 NS
*Severe CAD 5 either three-vessel or left main coronary artery disease.
Table 4. Cardiac Catheterization Rates in Various Subgroups
U.S. Rate
(%)
Canada
Rate* (%)
Relative Rate†
(95% CI)
Overall 71 27 2.6 (2.4–2.8)
Age .75 yr 48 17 2.9 (2.3–3.7)
Diabetes 68 25 2.8 (2.3–3.3)
Prior MI 66 26 2.5 (2.1–3.0)
Killip class $II 62 18 3.5 (2.8–4.5)
Anterior MI 72 26 2.8 (2.5–3.1)
Female 65 24 2.8 (2.4–3.2)
Recurrent ischemia 85 44 1.9 (1.8–2.1)
Uncomplicated 69 20 3.4 (3.1–3.8)
Complicated‡ 75 35 2.1 (2.0–2.3)
*p , 0.001 for all comparisons between U.S. and Canada. †Ratio of catheterization
rate in U.S. vs. Canada. ‡Complicated denotes those patients suffering from one or
more of the following post–myocardial infarction (MI) complications: shock, pulmo-
nary edema, congestive heart failure, recurrent ischemia, sustained ventricular tachy-
cardia, ventricular fibrillation or recurrent myocardial infarction.
CI 5 confidence interval.
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higher frequency in the U.S. across all age strata, the
likelihood for cardiac catheterization in both countries fell
dramatically with increasing age. This pattern was in direct
contrast to these patients’ corresponding likelihood for
severe CAD. For example, although over 80% of U.S.
patients of age #50 years underwent catheterization, the
probability of severe CAD in these young patients was only
approximately 10%. In contrast, only one half of elderly
patients (i.e., age 76 to 85 years) in the U.S., and less than
one quarter in Canada, underwent catheterization, yet these
patients had a nearly 30% probability of severe CAD.
Therefore, in Canada, the rate of cardiac catheterization in
the elderly was actually less than their corresponding prob-
ability of severe CAD.
Long-term implications. Given the observed differences
in diagnostic yield, the more aggressive U.S. catheterization
strategy identifies 48 more patients with 3VD and 26 more
with LMD per 1,000 MI patients than would be identified
in Canada (Table 5). Assuming that at least 50% of these
patients are eligible for, and undergo, surgical revasculariza-
tion (consistent with the observed coronary artery bypass
graft rate in the GUSTO trial), approximately 24 and 13
more patients with 3VD and LMD, respectively, undergo
revascularization in the U.S. relative to Canada. Yusuf has
reported that an initial strategy of coronary artery bypass
surgery affords a five-year mortality odds ratio of 0.32 (95%
confidence interval [CI] of 0.15 to 0.70) for LMD, and 0.58
(95% CI of 0.42 to 0.80) for 3VD compared with those
initially treated with medical therapy (12). Therefore, we
estimate that the five-year survival advantage that might
accrue from these marginal differences in severe CAD yield
amounts to 5.0 lives saved per 1,000 MI patients, in favor of
the U.S. strategy (Table 5).
Figure 2. Odds ratios and 95% confidence intervals for the likelihood of cardiac catheterization are shown on the right for the U.S. (solid
squares) and Canada (open squares). The corresponding odds ratios for the likelihood of severe coronary artery disease (CAD) are
displayed on the left. MI 5 myocardial infarction.
Figure 3. Bar graph depicting the frequency of cardiac catheter-
ization in the U.S. (solid bars) and Canada (open bars), plotted
with the corresponding predicted frequency of severe coronary
artery disease (gray bars) according to decade of age.
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DISCUSSION
This observational study is the first to compare post-MI
cardiac catheterization practices in the U.S. and Canada
regarding their respective abilities to detect severe CAD
after MI. Our findings suggest that the in-hospital post-MI
catheterization strategies in both countries are not ideally
designed to target patients with a higher likelihood of severe
CAD who may benefit from myocardial revascularization.
As a result, the diagnostic efficiency with which severe CAD
is detected in both countries is similar, and is in fact no
better than one might anticipate from a merely random
selection process. With no better efficiency than the U.S.
practice, (and a much lower rate of catheterization), the
Canadian strategy identifies substantially fewer patients
with severe CAD in the post-MI hospital phase. We
estimate that the long-term effect of these differences might
be significant, albeit modest (an estimated 5.0 lives saved
per 1,000 MI patients in favor of the U.S. strategy) when
considered in isolation from other differences in post-MI
management.
Previous studies comparing invasive versus noninvasive
post-MI strategies. Prior studies demonstrating major
variances in both regional and international cardiac cathe-
terization practices have generated a great deal of interest in
studying whether such variances might affect post-MI
outcomes (1–8,15). These studies have been inconclusive in
determining whether there is a definitive benefit with a
more aggressive catheterization strategy. In two previous com-
parisons of U.S. and Canadian practices, Rouleau et al. (1) and
Mark et al. (3) have reported benefits in angina symptoms and
quality of life associated with the more aggressive cardiac
catheterization strategy of the U.S. However, other studies
including several observational studies (2,7,8), a systematic
overview (4), the Veterans Affairs Non–Q-wave Infarction
Strategies In-Hospital trial (VANQWISH) (6) and the Or-
ganization for the Assessment of Strategies for Ischemic
Syndromes Study (OASIS) (16) have suggested that there is
no significant benefit to a more invasive management
strategy for MI and unstable coronary syndromes. However,
because the eventual survival advantage for coronary artery
bypass surgery over medical therapy may become evident
only after several years, any study comparing different
catheterization strategies requires several years of follow-up
(12,17). Only two reports (7,8) have had both adequate
power and long-term follow-up to examine these effects on
survival. Although neither of these studies showed a differ-
ence in survival between conservative and aggressive cathe-
terization strategies, the differences in catheterization fre-
quency and revascularization between the aggressive and
conservative strategies in these reports were substantially
less than observed in our GUSTO U.S.–Canadian compar-
ison.
The cardiac catheterization paradox: insights from study-
ing catheterization practice patterns. To gain insights
into the potential long-term implications of these differ-
ences in cardiac catheterization strategies, our study com-
pared the efficiency and overall effectiveness (diagnostic
yield) with which Canadian and U.S. post-MI testing
patterns identify severe CAD. Such an approach is based on
the premise that the mortality benefit of surgical revascu-
larization is highly dependent on the identification of such
high risk patients by cardiac catheterization and coronary
angiography. We anticipated that, due to more restricted
use, cardiac catheterization in Canada would be reserved for
MI patients deemed from clinical or noninvasive risk
stratification to be at higher risk for severe CAD, thereby
increasing Canada’s diagnostic efficiency. However, this was
not the case. The two countries shared remarkably similar
patterns of patient selection for cardiac catheterization—
patterns that were not designed to target patients with a
higher likelihood of severe CAD. In fact, paradoxically,
there was a tendency in both countries to perform less
catheterization on MI patients who are known to be at the
highest risk (18) and most likely to have underlying severe
CAD (elderly patients, diabetics and patients with previous
MI and congestive heart failure). Conversely, catheteriza-
tion rates were much higher in younger, lower risk patients
who were unlikely to have severe CAD. As a result of these
paradoxical trends in the application of cardiac catheteriza-
tion, the U.S. and Canada shared similar inefficiency in
severe CAD detection. In fact, given an estimated severe
CAD prevalence of approximately 19% in both countries, a
diagnostic efficiency of 17% in both countries suggests that
the selection process for catheterization in the U.S. and
Table 5. Estimation of Marginal Five-year Survival Benefit with U.S. Pattern of Cardiac Catheterization*
Marginal
Severe CAD
Yield†
Marginal
CABGs
Performed‡
Expected No. of
Deaths With
Medical Therapy§
Mortality Odds
Ratio With CABG
(95% CI)§
Marginal No.
of Lives Saved
(95% CI)
3VD 48 24 4.2 0.58 (0.42–0.80) 1.8 (0.84–2.4)
LMD 26 13 4.7 0.32 (0.15–0.70) 3.2 (1.4–4.0)
Total 74 37 8.9 5.0
*Estimates are based on 1,000 U.S. and 1,000 Canadian post–myocardial infarction patients. †Additional patients with severe coronary artery disease (CAD) identified in U.S.
compared with Canada, assuming diagnostic yields noted in Table 2. ‡Additional coronary artery bypass grafts (CABGs) performed for severe CAD in U.S. compared with
Canada, assuming a CABG rate of 0.50 for three-vessel coronary disease (3VD) and left main coronary disease (LMD), as derived from the pooled U.S. and Canadian GUSTO
samples. §Based on Yusuf et al. (12).
CI 5 confidence interval.
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Canada is no better in targeting severe CAD than a
completely random selection. These paradoxic practice pat-
terns attest to the complexities in the decision to perform
catheterization. Such a decision has been shown to be
strongly influenced by a number of nonclinical factors
including geographic region, local cardiac catheterization
lab availability, financial influences, fear of litigation and
patient expectations (5,19–21).
Implications of the cardiac catheterization rate–
efficiency relationship. Under circumstances of equivalent
efficiency, the higher rate of catheterization in the U.S.
results in a more than twofold higher proportion of patients
with severe CAD being identified in the U.S. compared
with Canada (;12 cases of severe CAD per 100 MI
patients identified in the U.S. compared with ;5 per 100
MI patients in Canada). Interestingly, Tu et al. (22), in
comparing rates of coronary bypass surgery, have also
alluded to a more than twofold greater detection of severe
disease in the U.S. compared with Canada. Therefore,
healthcare systems with lower rates of cardiac catheteriza-
tion such as Canada’s would have to increase the efficiency
of catheterization (i.e., optimize catheterization case selec-
tion) to maintain similar diagnostic yields of severe CAD to
higher rate healthcare systems such as the U.S. It remains to
be determined whether the use of clinical predictors for
severe CAD (23), or incremental predictive information
from noninvasive testing might improve patient selection,
thereby achieving this goal for lower rate systems.
Study limitations. There are several limitations to our
study. First, when evaluating post-MI prognosis, cardiac
catheterization comparisons cannot be interpreted in isola-
tion. Important prognostic information, independent of
coronary anatomy, can also be derived from noninvasive
post-MI cardiac testing, the results of which were not
available from our study (24,25). Second, it is impossible to
definitively ascertain the underlying prevalence of severe
CAD in the post-MI population from either country.
However, using both direct observations from the GUSTO
Angiographic Substudy and logistic regression modeling,
we do predict similar prevalences. Third, because angio-
grams were interpreted visually by the physician performing
the procedure, there exists a potential for interobserver
variability in assessing coronary artery disease severity.
However, all grades of stenosis severity, from no significant
disease to severe CAD categories, were similar in the two
countries, and reanalyzing our results using a criterion of
$50%, instead of $70% stenosis as the definition of
significant 3VD did not significantly alter the U.S.–
Canadian differences in severe CAD yield (other than
increasing the yield equally in the two countries). Fourth,
we examined only in-hospital catheterization rates. Because
there may be a substantial delay in acquiring cardiac
catheterization in Canada, it is possible that more of these
procedures were done on an outpatient basis. However,
several trials suggest that outpatient post-MI cardiac cath-
eterization rates differ minimally between the two countries
(2,3,26). In the Economic and Quality of Life Substudy of
the GUSTO trial, outpatient rates of catheterization at 1
year post-MI were similar between the U.S. and Canada
(23% vs. 19%, respectively, p 5 NS). Therefore, it is
unlikely that outpatient rates of catheterization in Canada
would have made up for the large (2.5-fold) inpatient
differences in severe CAD yield. Fifth, it must be recog-
nized that our results reflect only the average catheterization
strategies in the two countries; they are not sensitive to the
major regional differences in catheterization practices that
exist within the U.S. and Canada (3,5). Finally, our pro-
jected influence on long-term survival used a weighted
estimate of survival differences between coronary artery
bypass surgery and medical therapy based on clinical trials
data between 1972 and 1984 (12). Advances in medical
therapy and surgical technique, as well as the increased use
of percutaneous coronary interventions (angioplasty) render
an estimate of the current advantage of revascularization
(bypass surgery or angioplasty) over medical therapy for
severe CAD more complex. Given these limitations, the
true impact of identifying severalfold more patients with
severe CAD with U.S. catheterization practices remains
speculative.
Conclusions. Our study provides new insights into the
diagnostic properties of two different cardiac catheterization
strategies. More restricted catheterization practices, such as
those in Canada, if not accompanied by increased diagnostic
efficiency, identify substantially fewer patients with high risk
coronary anatomy than the more aggressive U.S. practice.
These differences could have modest, but significant impli-
cations on long-term post-MI outcomes. Both countries
might substantially improve the efficiency of post-MI man-
agement by more effectively targeting higher risk patient
subgroups for cardiac catheterization. A better understand-
ing of the effects of these differences in catheterization
utilization, particularly within the context of independent
prognostic information derived from noninvasive post-MI
risk stratification, will require long-term study, and is crucial
to optimizing post-MI healthcare delivery in an era of
constrained financial resources.
APPENDIX
APPENDIX: RISK MODEL FOR SEVERE CAD
Probability of severe CAD 5 1/[1 1 exp (2L)], where L 5
23.822 1 0.0376 (Age) 2 0.6058 (Gender) 2 0.3645
(HxSmk) 1 0.3553 (Lipids) 1 1.0252 (Prev MI) 1 1.7153
(Prev CABG) 2 0.8527 (Prev PTCA).
Explanatory Notes
1. For Gender: male 5 0, female 5 1.
2. HxSmk: history of cigarette smoking (smoker 5 1,
nonsmoker 5 0).
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3. Lipids: history of hypercholesterolemia (yes 5 1, no 5
0).
4. Prev MI: history of previous myocardial infarction (yes 5
1, no 5 0).
5. Prev CABG: previous coronary artery bypass surgery
(yes 5 1, no 5 0).
6. Prev PTCA: previous percutaneous transluminal coro-
nary angioplasty (yes 5 1, no 5 0).
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